QT time in patients treated with alprenolol or placebo after myocardial infarction.
AUTOR(ES)
Nyberg, G
RESUMO
Studies were made on the effects of long-term beta-blockade on the QT interval in patients discharged alive from hospital after myocardial infarction. The patients (n = 230) in this study constituted all those who participated in the alprenolol study on postmyocardial patients in Göteborg, Sweden. The study was double-blind (alprenolol 200 mg b.i.d. or placebo) and randomised. The patients were divided into 4 risk groups (1-4) with different predicted mortality. The electrocardiograms before and after 8 weeks of treatment were analysed with respect to heart rate and QT time. There was a decrease in heart rate of about 10% in the alprenolol treated patients. The QT time was not significantly influenced by alprenolol. The rate corrected QT time (QTc) decreased in the subgroup of the most severely diseased patients (subgroup 4) treated with alprenolol.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=514695Documentos Relacionados
- Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
- Left ventricular systolic time intervals in patients with acute myocardial infarction.
- Use of lead adjustment formulas for QT dispersion after myocardial infarction.
- Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction.
- Investigation of symptom free patients after myocardial infarction.
